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In  vivo-formed  antigen-antibody complexes  cause  transient  glomerulonephritis 
and vasculitis in experimental animals when appropriate antigens are administered 
to  unimmunized  animals in  a  single  dose  (1,  2).  Similar antigens  administered in 
multiple doses induce chronic  disease  (1,  3).  Antigen,  antibodies, and  complement 
components  have been  demonstrated in lesions produced in  this manner.  Further- 
more, antigen-antibody complexes have been shown as causative agents of glomerulo- 
nephritis in human  systemic lupus  erythematosus  (4),  acute  poststreptococcal glo- 
merulonephritis  (5),  malaria  (6),  and  other  conditions.  However,  in  experimental 
models and in human diseases, the characteristics of immune complexes that become 
entrapped by vascular  and  glomerular basement  membranes  to  cause  disease are 
not fully understood. In addition, detailed descriptions are not available on the char- 
acteristics of immune complexes that form in vivo from the native antibodies and the 
antigens  that  are  introduced experimentally in  animals  or by disease processes in 
man.  Similarly, quantitative information on  the fate  of such  complexes is lacking. 
When antigens  are  administered to  immunized animals in  small doses  or if im- 
mune  complexes  are  given  to  nonimmunized  animals,  the  immune  complexes  are 
removed rapidly in part by the reticuloendothelial system (7,  8). Weigle (9) showed 
that  if  intravenously injected  antigen-antibody complexes  are  prepared  at  equiv- 
alence or in slight antigen excess, they are quickly removed from  the circulation of 
rabbits and  that similar complexes prepared in large antigen excess persist longer. 
He concluded that the size of the complexes played a  major role in their clearance 
from the circulation. Cochrane and Hawkins (10)  also indicated that immune com- 
plexes greater than  19S are quickly removed from the circulation of guinea pigs and 
that small antigen-antibody complexes persist in the circulation. These investigators 
suggested that the immune complexes had to exceed a  certain critical size and that 
vascular permeability had to be increased before complexes were entrapped by vascu- 
lar or glomerular basement membranes. The half-life of the complexes that are rapidly 
removed has not been well defined and the role of the complement-fixing ability of 
these complexes has not been characterized fully. 
* This investigation was supported by U.  S. Public Health Service research  grant No. 
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The current studies were undertaken to examine in rabbits the disappearance 
of  intravenously administered soluble antigen-antibody complexes in relation 
to their size, complexity (number of antigen and antibody molecules in a  com- 
plex), and complement-fixing  ability. The presented data show that the rapidly 
cleared complexes fix complement well and consist of more than one antigen 
and  two  antibody molecules.  Complexes  composed  of  one  antigen and  two 
antibody molecules do not fix complement effectively and are removed slowly 
from the circulation. Furthermore, complexes prepared from antibodies altered 
by reduction and alkylation of  interchain disulfide bonds do not fix comple- 
ment  effectively and  their  clearance from  circulation is  markedly retarded. 
However,  the  clearance of  unaltered immune complexes was not affected by 
depletion of several complement components. These observations prompted the 
conclusion that complement fixation is not essential to the clearance of immune 
complexes, but the characteristics of complexes that permit complement fixa- 
tion closely parallel those  that predispose complexes to rapid clearance from 
the circulation due to uptake by the reticuloendothelial system. 
Materials and Methods 
Preparati°n °f Antigens'--Several antigens were purified f°r immunizati°n and  preparation 
of antigen-antibody complexes. Unaggregated human serum albumin (subsequently desig- 
nated I-ISA)  1 was obtained by gel filtration of crystallized human albumin (Mann Research 
Laboratories Inc., New York) with a column of Sephadex G-200 (5 cm  2 X  95 cm volume; 
equilibrated with 0.2 ~t sodium borate, 0.15 ~t NaC1, pH 8.2). 0nly the symmetrical mono- 
meric HSA peak was pooled for further  use. The serum of a patient with Waldenstr6m's 
macroglobulinemia was used as the source of the human 3'M-globulin for immunization and 
for preparation of immune complexes. The serum was first submitted to preparative electro- 
phoresis (11) and then the fraction of the macroglobulin with the highest protein concentra- 
tion was applied to a calibrated Sepharose 4]3 column (Pharmacia Fine Chemicals, Inc., Pis- 
cataway,  N. J.)  (5 cm  2 X  95  cm volume, equilibrated with 0.2  ~  sodium borate,  0.15 
of NaC1, pH 8.2). The symmetrical peak of unaggregated '/'M-globulin with  )t-chains was 
pooled for further use. Bence Jones proteins were isolated from the lyophilized urine of the 
same patient. This was achieved with preparative  electrophoresis and gel filtration  as de- 
scribed above. The symmetrical peak of the dimerized X-chains was pooled for further  use. 
Human 3,G-globulin was obtained from human fraction II  (Mann Research Laboratories, 
New York) by gel filtration over Sephadex G-200 to remove aggregated material and con- 
taminants. The purified antigens were used within 2 wk for preparation of antigen-antibody 
complexes; during this time they were stored at 4°C. The protein concentrations were deter- 
mined by the Folin procedure. 
Several New Zealand rabbits were immunized with each of the purified antigens for pro- 
duction of antibodies. The antigens were emulsified  with complete Fretmd adjuvant and given 
subcutaneously or intramuscularly at weekly intervals in doses of 1-2 mg per rabbit for a 
minimum of 4 doses. Thereafter, weekly bleedings of 30-50 ml were obtained; the serum was 
harvested  and stored  at  --20°C.  In 4-6-wk intervals  additional  doses of the  appropriate 
IAbbreviations  used  in  this  paper:  Anti-HSA  (aHSA in figs.), antibodies to HSA; Anti- 
HSA125I red. and alk., reduced and alkylated anti-HSA125I;  CoF, cobra venom factor; HSA, 
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antigens were administered and the bleedings were continued at 1-2-wk intervals. For each 
antigen the antisera were pooled from several rabbits. 
Isolation of Antibodies.--The solid-phase immunoadsorbent technique of Ax~n and Porath 
was adapted for the preparation of sufficient amounts of purified antibodies (12). Sepharose 
4B was washed with distilled water and with 0.2 ~ sodium borate, 0.15 ~ NaC1, pH 8.2;  then 
the pH was brought to 11.0 with 1.0 ~ NaOH in a pH stat. Subsequently a solution of cyano- 
gen bromide was added to provide 1 mg of CNBr for each milligram of dry Sepharose; the 
pH was maintained at 11.0 4- 0.2 for 20 min with 1.0 ~  Na0H. The activated Sepharose was 
washed in a  fritted disc glass filter with copious amounts of cold distilled water and then 
with successive 100  ml portions of the cold borate buffer cited above.  Finally a  slurry of 
Sepharose was made and the protein to be coupled was added at a ratio of more than 2 mg of 
dry Sepharose to 1 mg of protein. This mixture was slowly tumbled by rotor at 4°C overnight. 
Subsequently, the Sepharose slurry was poured into a glass column, washed with the borate 
buffer, and then with a solution of 0.01 M HC1, 0.15 M NaC1. At each step the washing was 
carried out until no further protein was detected by absorbance at 280 m/z. After this,  the 
column was washed with the borate buffer to remove all of the dissociating solution. The 
amount  of protein recovered was determined and  the amount of  protein coupled  to  the 
Sepharose was calculated. In this manner columns of solid-phase immunoadsorbents were 
prepared with HSA, a WaldenstrSm's macroglobulin, a  k-Bence Jones protein, and normal 
human "yG-globulins. 
The solid-phase immunoadsorbent columns were utilized for isolation of specific antibodies. 
In this procedure the appropriate antiserum was deeomplemented by heating at 56°C for 30 
rain, cooled, and centrifuged at 1500 g to remove any insoluble material. After this, the anti- 
serum was applied to the appropriate immunoadsorbent column at a flow rate of 10-20  ml/ 
hr; the column was washed with the borate buffer cited above until the effluent contained no 
protein by 280 m/z absorbance. Thereafter, the antibodies were eluted with a solution of 0.01 
HC1,  0.15  M NaC1,  or with  3.0  ~  sodium  thiocyanate  (13).  The  effluent fractions were 
collected and  280  m/z  absorbance was determined. The protein-containing fractions were 
pooled immediately and dialyzed against cold borate buffer. Upon neutralization or removal 
of thiocyanate, some precipitate formed; this was separated by centrifugation. These prepara- 
tions of eluted antibodies were either lyophiUzed from distilled water for storage or processed 
for further use. 
Iodination  of Antibodies.--The isolated antibodies were trace-labeled with 125I with 1-2 
moles of iodine per mole of protein, using the iodine monochloride method  (14).  After re- 
moval of unbound radioactivity by Dowex 1 X  4 in chloride phase or by dialysis, the protein 
solutions were applied to columns of G-200  Sephadex in borate buffer (same as above)  to 
remove any high molecular weight antibodies or aggregated material. The symmetrical peak 
of unaggregated antibodies was pooled and used for preparation of complexes. Samples of the 
labeled antibodies were reduced and alkylated as previously described (15) before passage 
over G-200  Sephadex column. The same method of iodination was used to prepare labeled 
antigens. 
Preparation and Characterization of Immune Complexes.--Once  the 125I-labeled antibodies, 
free of aggregates, had been obtained, quantitative precipitin curves were constructed to 
determine equivalence for each antibody preparation. To  obtain soluble antigen-antibody 
complexes at  a  desired antigen excess,  antibodies were added to  antigen solutions. These 
preparations were allowed to incubate at 4°C for a minimum of 2 hr, but at times were stored 
at this temperature overnight. Before utilization for further studies they were centrifuged at 
1500 g for 15 rain. 
The  size  and  heterogeneity of  antigen-antibody complexes was  determined by  linear 
sucrose density gradient ultracentrifugation  (16). 0.40  ml  specimens were  applied to  the 
gradients when using a Beckman-Spinco SW41Ti  rotor (Beckman Instrument Co., Fullerton, 716  ELIMINATION  OF  SOLUBLE  COMPLEXES  FROM  CIRCULATION 
Calif.) and 0.20 ml specimens were applied when using a  SW65Ti rotor. The gradients were 
harvested from the bottom and radioactivity in each fraction was assayed by an automatic 
well-type  gamma  counter.  The  radioactivity in  each  fraction was  plotted  as  per  cent  of 
gradient volume (see Fig. 2). In this manner the separations from run-to-run could be easily 
compared and were shown to be highly reproducible. The unbound 6.6S antibodies served as 
a convenient marker to calculate the sedimentation coefficient of complexes. At times human 
"),M- or rabbit "gG-globulins were used as markers in the gradients. 
The complement-fixlng ability of immune complexes was determined by the method of 
Wasserman and Levine (17) as modified by Gilliland et ai. (18) to yield a final volume of 3.5 
ml in each tube. 1.5 CHs0 units of guinea pig complement were used per tube and serial two- 
fold  dilutions of  complexes  were  carried  out.  Complement-fixing ability was  expressed  in 
micrograms of antibody required to fix 50% of complement in this system. All preparations 
of  complexes  were  dialyzed  against  a  0.1  •  tris(hydroxymethyl)aminomethane  (Tris)- 
HC1,  0.15 ~  NaC1 buffer, pH  7.5,  before  testing  for  complement  fixation  to  remove  the 
sucrose or other buffers in which the complexes were prepared.  The normal and depleted 
levels of rabbit complement were assayed by the methods cited above. 
Administration  of Complexes and their Disappearance  from Rabbit Circulation.--The  im- 
mune complexes,  containing 2-4 mg of antibody, were administered intravenously to non- 
immunized rabbits that had been pretreated with sodium iodide in drinking water for  1-2 
days. The injections were given into the marginal vein of one ear and the samples were ob- 
tained from the other ear 5, 10, 30, and 60 rain after the injection. Subsequent specimens were 
obtained at longer intervals. The experiments were usually terminated after 4 days to avoid 
the autologous newly formed antibodies from complicating the experiments. In preliminary 
experiments, rabbits were shown to start immune clearance of the antigen 5-6 days after the 
injection of immune complexes. 
About 2.0 ml of blood was obtained at each bleeding. The clot was allowed to form; the 
serum was harvested and stored at 4°C for further studies. Accurately measured portions of 
serum were assayed for the presence of 125I. Additional samples of serum from serial bleedings 
were diluted 1:4 with borate buffer and submitted to density gradient ultracentrifugation as 
described above. 
Depletion of Complement Components.--To  assess  directly the role of  complement com- 
ponents in the elearance of immune complexes from the circulation, rabbits were depleted of 
complement components by being given either heat-aggregated human 3'G-globulin or the 
purified anticomplementary cobra venom factor. The former was prepared according to the 
method of Christian (19)  and the latter was purified by ion-exchange chromatography and 
gel filtration according to  the procedures of  Cochrane et al.  (20).  Further details of these 
preparations and their evaluation are given in another paper, e In order to suppress comple- 
ment by the cobra venom factor (subsequently abbreviated CoF), the 3 kg rabbit was given 
225 units of CoF intraperitoneally at 24, 20, and 18 hr before injection of complexes. 320 units 
of CoF were given intravenously 30 min before the complexes and thereafter once a day for 
the duration of the experiment. To suppress complement by aggregated human 3'G-globulin, 
25 mg were given intraperitoneally 3 and 2 hr before the complexes, 5 nag intravenously at 1 
hr, and 10 mg intravenously at 30 rain before the complexes. Thereafter the rabbit received 25 
mg intraperitoneally at 4 hr and subsequently twice a day throughout the experiment. Serum 
for complement assays was obtained before the next injection of agents for depletion of com- 
plement. These serum specimens were frozen within 1 hr at --70°C and stored until assayed 
for total hemolytic complement. 
2 Arend, W. P., and M. Mannik. Studies on antigen-antibody complexes. II. Quantifica- 
tion of tissue uptake of soluble complexes in normal and complement-depleted rabbits.  Sub- 
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Analysis of Data.--The amount of radioactivity in sequential serum specimens was deter- 
mined. The concentration of isotope per unit volume of serum at zero time (time of injection) 
was obtained by extrapolation of the 5, 10, and 15 rain values, assuming that complete mixing 
has occurred at 5 rain after injection. The zero time concentration was taken as 100% of the 
concentration of the injected dose. The per cent of remaining isotope was calculated for each 
bleeding and was plotted on semilogarithmic  paper against time. In these calculations no 
allowance was made for the blood drawn from rabbits for analysis. Starting with the exponen- 
tial component with the longest half-life,  the graphic "peeling" method  (21) was used to 
obtain an estimate of the half-life and the percentage of each exponential component as well 
as the number of such components.  Some data were further analyzed by a CDC 6400 com- 
puter by the SAAM 22 program of Barman and Weiss (22). Each disappearance curve was 
tested for the estimated number of exponential components  as well as for one more and one 
less exponential component.  The goodness of fit was judged by the sum of squares  of the 
differences between observed and calculated values, the estimates of parameter variance, and 
presence or absence of any progressive deviations of observed and calculated values. 
~S~TS 
Characteristics  of Isolated  Antibodies  Used for  the  Preparation  of Immune 
Complexes.--Several  columns  containing HSA coupled to 4B  Sepharose were 
used repeatedly for isolation of antibodies to HSA (subsequently abbreviated 
anti-HSA). There was no apparent loss of the capacity of these columns to bind 
antibodies.  During  the  elution  of anti-HSA with 0.01  M  HC1,  0.15  ~  NaC1, 
the antibodies emerged as the pH of the effluent dropped as indicated in Fig. 1. 
The eluted proteins were pooled and then neutralized by dialysis against borate 
buffer  (see  Materials  and  Methods).  During  this  step  5-10%  of  the  total 
protein precipitated. The nature of the precipitated material was not elucidated, 
but when 125I-labeled HSA was coupled to Sepharose 4B,  then radioactivity of 
the antigen was not recovered in the precipitate; this  indicated that the pre- 
cipitate did not  contain antigen-antibody complexes  and  suggested that  the 
precipitate represented  denatured  antibodies.  Mter  iodination with  125I, the 
antibody preparations were  passed over columns  of Sephadex  G-200  and  the 
homogeneous protein peak that eluted as "yG-globulin was utilized  for the prepa- 
ration of immune complexes.  Immunoelectrophoresis of the antibody prepara- 
tion after gel filtration disclosed only 3,G-globulin; furthermore,  Ouchterlony 
plate analysis of the same material disclosed only one precipitin line with goat 
antisera  against  rabbit  serum.  Purified  and  labeled  antibodies  to  the  other 
antigens were similarly composed of only rabbit 3,G-globulin. 
To determine that the biological half-life of the isolated antibodies was not 
altered by the elution procedures, two rabbits received simultaneously normal 
rabbit 3,G-globulin labeled with 1~iI and anti-HSA labeled with i25I. The serum 
disappearance curves of the two materials were superimposable and the graphi- 
cally estimated half-lives were nearly identical for the ~G-globulin and anti- 
HSA: 74 and 76 hr respectively in both rabbits. Similar half-lives were obtained 
for  anti-3,M  labeled with i25I. 
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anti-HSA  125I were prepared at fivefold antigen  excess  and portions of these 
complexes were analyzed by density gradient ultracentrifugation before injec- 
tion into rabbits.  Using the  6.6S  peak  of unbound antibodies  as  a  reference 
point,  the sedimentation coefficients  of complexes were calculated. A  discrete 
llS peak of complexes was present (see Fig. 2); this was followed by a spectrum 
of complexes ranging from 14S to 22S  (at 10% of gradient volume) and desig- 
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FIG. 1. Elufion of anti-HSA (aHSA) from an HSA-Sepharose 4B column. 200 ml of de- 
complemented antiserum was applied to the column. After the serum had run through, the 
column was washed with borate buffer until no further protein eluted. At that time, elution 
with 0.01 ~t HC1, 0.15 ~a NaCI  was started. As the pH of the effluent decreased, protein was 
eluted. The peak indicated with a bar was pooled for further study. 
nated  as  >llS  complexes.  However,  if a  Waldenstr6m's  macroglobulin was 
used  as  a  marker,  the  sedimentation  coefficients  for  all  the  complexes were 
higher.  In  one  experiment  complexes were  prepared  from anti-HSA12~I  and 
HSA131I in fivefold antigen excess and analyzed on density gradients. The molar 
ratio  of  the  antibody and  antigen  in  the  llS  peak  was  calculated from the 
specific  activities  of  these materials,  using  the  molecular weights  of  145,000 
(23)  and 67,000  for the anti-HSA and HSA respectively. In the center of the 
llS peak of complexes,  the molar ratio of antibody to antigen  approached 2 
(2.05  and 1.89 in separate experiments). The molecular weight of the llS peak M.  MANNIK~  W.  AREND~  A.  HALL~  AND  B.  GILLILAND  719 
was estimated at 357,000 by the method of Martin and Ames (16). Therefore 
it was concluded  that  these  complexes were composed of one HSA  and  two 
anti-HSA molecules. 
Several density gradient separations were performed on HSA-anti-HSA12~I 
complexes at fivefold antigen excess and appropriate pools were made  (illus- 
trated in Fig. 2)  to obtain sufficient >  llS and llS complexes for complement- 
fixation studies.  The complexes at fivefold antigen  excess contained 46%  of 
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FIG. 2.  Density gradient ultracentrifugation pattern of HSA-anti-HSA125I complexes at 
fivefold antigen excess. A gradient of 10-30% sucrose and SW41Ti rotor were used; the top 
of the gradient is represented by 100% of gradient volume. Pool I represents > llS complexes 
that range from 14S to 22S, pool II, llS complexes,  and pool III, unbound 6.6S antibodies. 
>  llS complexes, 34% of llS complexes, and 20% of 6.6S antibodies. The >  llS 
complexes fixed complement effectively in that 0.095  #g of antibody was re- 
quired to fix 50% of complement. The llS  complexes required  10 times more 
antibody protein (0.97  #g) to fix the same amount of guinea pig complement. 
The llS complexes were unstable in the absence of excess antigen in that they 
reequilibrated to form some >  llS complexes and some free 6.6S  antibody as 
determined by repeated ultracentrifugation. Therefore it is likely that the com- 
plement-fixation  data  overestimated  the  ability  of  the  llS  complexes to fix 
complement. 
The  soluble  complexes of HSA-anti-HSA125I, prepared  at fivefold antigen 
excess  on  several  occasions,  were  injected  intravenously  into  seven  rabbits. 720  ELIMINATION  OF SOLUBLE  COMPLEXES  FROM  CIRCULATION 
The disappearance curves of these complexes were composed of three exponen- 
tial  components.  The  serum  disappearance  curves  for  two  such  rabbits  are 
illustrated in Fig. 3. The two sets of experimental points and the corresponding 
curves calculated by computer were nearly superimposable. The half-lives of the 
exponential components and their percentages are recorded in Table I. In earlier 
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Fie. 3.  Disappearance of HSA-anti-HSAI~5I and HSA-anti-HSA125I red. and alk. com- 
plexes from the circulation of rabbits. The solid circles (@) and the solid triangles (&) indi- 
cate the experimentally observed points for the disappearance of HSA-anti-HSA125I  com- 
plexes in two rabbits. The solid lines indicate the curves fitted to these points by computer. 
The larger  broken lines (- -) indicate the three exponential components that compose the curve 
indicated by the heavier solid line fitted to the experimental points marked by solid circles. 
The open circles (O) indicate the experimentally observed points for the disappearance of 
HSA-anti-HSAI~I red. and alk. complexes in one rabbit. The solid line indicates the curve 
fitted to these points by computer. The smaller broken lines (----) indicate the two exponential 
components  that compose this curve. 
experiments the values were graphically determined and  similar values  were 
obtained. The fastest exponential components had a  mean half-life of 0.24 hr 
in seven experiments  (range 0.16-0.37  hr)  and 44.3%  (range 40-51%)  of the 
radioactivity was eliminated from the circulation with this half-life. The  other 
two exponential components had longer half-lives. The second component had 
a  mean half-life of 4.3  hr  (range 2.8-7.5  hr),  and 38.3%  (range  32-40%)  was 
eliminated from the circulation with this half-life. The third and slowest com- 
ponent had a mean half-life of 47 hr (range 40-65 hr) and 17 %  (range 13-20 %) M.  MANNIK,  W.  AREND,  A.  HALL,  AND  B.  GILLILAND  721 
of radioactivity was eliminated from circulation with this half-life. The haft- 
life of HSA125I alone was 57 hr and the equilibration phase (first exponential 
component) had a half-life of 2.3 hr. 
Sequential serum specimens, obtained from rabbits in whom the disappear- 
ance of complexes was studied, were submitted to density gradient ultracen- 
trifugation. The > 11S complexes were quickly removed (see Fig. 4). Smaller 
complexes and the 6.6S antibodies dearly persisted longer in the circulation. To 
determine the half-life of the complexes of different sizes,  counts remaining 
TABLE I 
Disappearance of HSA-Anti-HSA  Complexes .from the Circulation: Half-Lives of Exponential 
Components and the Percentages of Antibodies in each Component 
Nature of complexes 
administered 
HSA-anti-HSAt~I; 
5-fold Ag excess 
HSA-anfi-HSA126I; 
5-foldAgexeess 
HSA-antLHSA125I; 
5-foldAgexcess 
HSA--anfi-HSAt~I 
red. &alL; S-fold 
Agexcess 
HSA-antbHSAt~I 
red. &alk.; S-fold 
Agexcess 
Rabbit No. 
Mean values 
and ranges 
for five 
rabbits 
M30 
M31 
Mean values 
and ranges 
for two 
rabbits 
M14 
First (fastest) component 
t  ~* 
(hr) 
O.  25 
(0.16-0.37) 
0.21  4- 0.02 
0.24  4- 0.02 
2.1 
(2.0  & 2.2) 
1.98  4- 0.28 
Second component 
Per cent*  t  ~* 
(hr) 
t5  4.6 
(40-51)  (2.8-7.5) 
41.0  4- 2.(  3.59 4- 0.47 
44.5  4- 2.~  3.83  4- 0.61 
39  63 
(38  & 40)  (57  & 69) 
43.2  4- 2A  63.0  4- 6.9 
Third component 
51 
(60  &62) 
54.2  4- 2A 
Per cent*  t  ~* 
38  (4 4£5 ) 
(32-40) 
39.8 4- 2.4  40.0 -4- 5.~ 
37.9  4- 2.;  47.8  4-9.~ 
Per cent* 
17 
(13-20) 
19.0 --I- 2.2 
17.0 4- 2.4 
* In experiments analyzed by computer, 1 SD of variance is given. For other experiments the graphically estimated 
values are given with the mean and the range of values. 
under each of tlle components were estimated and plotted directly on semi- 
logarithmic paper against time (see Fig. 5). In this manner the half-lives of the 
>llS,  llS,  and  6.6S  materials  were  estimated.  The  half-life of  the  >llS 
components was 0.16-0.28  hr and these curves were straight lines on semi- 
logarithmic plots and were therefore single exponential components. The dis- 
appearance curve of the llS complexes was composed of two exponential com- 
ponents,  and these were thought to represent  equilibration and catabolism. 
The catabolic phase  of  llS  complexes and  the 6.6S  antibodies appeared  to 
parallel each other. 
HSA-anti-HSAI2q complexes were prepared at 20-fold antigen excess. This 
preparation was analyzed by density gradient ultracentrifugation as described 
above.  In  these  complexes  32%  of  the  radioactivity sedimented  as  >llS 
complexes and 48%  as  llS  complexes.  When these complexes were injected dd~ 
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into a  rabbit,  the disappearance curve showed three exponential components 
similar to previous experiments, but the per cent of the fastest component was 
decreased. On graphic analysis the fastest component had a half-life of 0.40 hr; 
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FIO. 5.  Disappearance curves of the individual components of HSA-anti-I-ISA I~5I com- 
plexes prepared at fivefold antigen excess. The counts per 4 rain remaining under the > llS 
and llS complexes and 6.6S peak on density gradient ultracentrifugation were estimated for 
six bleedings and plotted against time. The >llS complexes (X  X) disappeared quickly 
as one exponeatial componeat, whereas the llS complexes (0  O) and the 6.6S antibodies 
(e---O) had two exponential components. 
34 %  of radioactivity was eliminated with this half-life.  The second and third 
exponential components had half-lives comparable to the complexes prepared 
at  fivefold antigen  excess.  Thus  in  this  experiment  the  >llS  material  was 
decreased and a corresponding decrease was observed in the first component of 
the disappearance curve of the immune complexes. 724  ELIMINATION OF  SOLUBLE  COMPLEXES  FROM  CIRCULATION 
Reduction  and  alkylation of  interchain  disulfide bonds  of  antibodies  has 
been shown to decrease markedly the efficiency of these molecules to fix com- 
plement when  they interact with  the  specific  antigen  (24).  For  this  reason 
complexes were prepared at fivefold antigen excess from HSA and reduced and 
alkylated anti-HSA12~I (subsequently designated anti-HSA125I red.  and alk.). 
Density gradient ultracentrifugation of  these  complexes showed that  >11S 
and llS complexes and 6.6S antibodies were present in proportions similar to 
those  in  the  experiments with  anti-HSA125I.  The  complexes prepared  from 
reduced and alkylated antibodies were virtually unable to fix complement in 
that more than 63/~g was required to fix 50%  of complement in the system 
employed. When these complexes were administered intravenously, their dis- 
appearance from the circulation was composed of only two exponential com- 
ponents (see Fig. 3 and Table I). The first component had a mean half-life of 
2.1 hr (range 2.0-2.2 hr) and 40.3 %  (range 38-43 %)  of the radioactivity was 
eliminated from circulation at this half-life. The second component had a mean 
half-life of 63 hr (range 57-69 hr)  and 58.7 % of radioactivity was eliminated 
with this half-life. Density gradient centrifugation on sequential serum samples 
showed that the > llS, llS, and 6.6S components disappeared from the circu- 
lation in parallel without a rapid loss of the > llS complexes as illustrated in 
Fig. 4  (right). 
Disappearance of X-Anti-X  and "yG-anti-'yG Complexes.--To  explore  the 
disappearance of immune complexes with other  antigens, dimeric human X- 
Bence Jones  proteins  (molecular weight  of  about  40,000)  and  human  3'G- 
globulin were chosen as antigens. The antibodies were isolated, labeled with 
1~5I, and processed in the same manner as described for the  anti-HSA. The 
labeled antibodies to a X-Bence Jones protein will be designated anti-X12~I and 
the antibodies to 7G-globulin will be designated as anti-~/G 125I. The latter 
predominantly contained antibodies to the Fc fragments. In addition, samples 
of antibodies to both antigens were reduced and alkylated. 
Only 40 % of the 6.6S anti-Xl~I and reduced and alkylated anti-X125I prepara- 
tion precipitated at equivalence with the X-Bence Jones proteins used as the 
antigen; the remaining 60% was not bound to antigen, as shown by density 
gradient centrifugation. Presence of idiotypic antibodies (25) could not account 
for the failure of precipitation since the same Bence Jones protein was used for 
immunization, isolation of antibodies, and preparation of complexes.  Soluble 
complexes at  10-fold  antigen excess  were prepared  with  anti-Xl~sI and with 
reduced and alkylated anti-X1~sI. Density gradient ultracentrifugation showed 
that these complexes were composed of > 9S complexes,  a discrete peak of 9S 
complexes, and 6.6S antibodies. In these complexes 20 % of antibodies were in 
the  >9S  complexes.  The X-anti-X~2sI complexes fixed  complement well  and 
the X-anti-X125I reduced and alkylated complexes fixed no complement. The 
above-mentioned  complexes  were  given  intravenously  to  separate  rabbits. lV[.  MANNIK~  W.  AREND~  A.  HALL~  AND  B.  GILLILAND  725 
The disappearance curve of the complexes with intact antibodies was composed 
of three exponential components (see Table II); the fastest component had a 
hag-life of 0.09 hr and 19% of the labeled antibodies were removed from the 
circulation with this half-life. The disappearance curve of the complexes with 
reduced and alkylated antibodies was composed of only two exponential com- 
ponents  (see  Table  II).  The initial rapid removal of  complexes was  clearly 
absent when the complexes were prepared with reduced and alkylated anti- 
bodies. 
TABLE  II 
Disappearance of Other Immune Complexes from the Circulation: Half Lives of Exponential 
Components and the Percentages of Antibodies  in Each  Corn  wnent 
Nature of complexes 
administered 
X-anti-XtmI; 10-fold 
Ag excess 
)k-anti-XlssI red.  & 
alk; 10-fold Ag ex- 
cess 
3,G-anti-TG~I;  S- 
fold  Ag excess 
-yG-anti-'yGX~Sl;  5- 
fold  Ag excess 
,yG-anti-,yG1~51  red. 
& alk.;  5-fold  Ag 
excess 
,TCr-anfi-3,G1251  red. 
& alk.; 5-fold Ag 
egcess 
3,M-anti-3"M1 ~I; 5- 
fold Ag excess 
TM-anti-TMtmI red. 
& alk.; 5-fold Ag 
excess 
Mll 
M29 
M33 
M36 
M34 
M37 
M20 
M21 
f 
First (fastest) component  Second component 
J 
t  ~* 
(hr) 
0.09  4-  0.00 
1.20  4- 0.57 
0.26  4-  0.02 
0.16  4- 0.03 
1.00  4- 0.16 
1.9  4-  0.19 
0.20  4- 0.01 
0.25  4- 0.04 
Per cent* 
18.9  4-  2.5 
18.0  4- 3.3 
37.0  4-  1.3 
66.5  4-  1.3 
40.1  4- 2.7 
51.0  4- 2.2 
59.8  4-  1.3 
31.1  4- 2.5 
t  ~*  Per cent* 
(hr) 
1.45  4- 0,20  40.8  4- 2.2 
38.5  4- 2,5  81.9  4- 3.0 
5.96  4- 0.66  39.4  4-  1.7 
4.08  4- 0.66  25.7  4-  1.6 
43.4  4- 3.0  61.3  4-  2.8 
41.5  4- 2.8  48.8  4-  2.1 
6.48  4-  1.23  33.5  4- 3.4 
4.20  4-  0.59  47.6  4- 3.4 
I 
Third component 
t  ~*  Per cent* 
(hr) 
27.7 -4-  2.1  40.7  4-  1.9 
81.5  4-  9.8  24.0  4-  1.8 
43.3  4-  12.2  7.8  4.  1.7 
49.6  4- 33.9  7.7  4- 3.9 
49.5  4-  11.4  22.4  4- 3.1 
* These experiments were analyzed by computer,  1 sD of variance is given. 
Two separate purifications of antibodies to human 3,G-globulin were carried 
out. Anti-~/G~25I and reduced and alkylated anti-3"G~25I were  prepared from 
each purified batch. With the first batch, 60-65 % of antibodies precipitated at 
equivalence  and  with  the  second batch,  80%  of  antibodies precipitated  at 
equivalence. Soluble complexes at fivefold antigen excess were prepared with 
all four preparations of antibodies. On density gradient ultracentrifugation the 
complexes with intact and reduced and alkylated antibodies gave patterns of 
> 135, 13S, and 10S complexes and 6.65 antibodies. The 6.65 peak was used as 
a marker for the calculation of sedimentation coefficients. The amount of > 135 
complexes varied with the two preparations of antibodies. In the first prepara- 726  ELIMINATION OF  SOLUBLE  COMPLEXES  FROM  CIRCULATION 
tion of antibodies (used for rabbits M33 and M34), 39 % of antibodies were in 
the > 13S fractions and in the second preparation of antibodies 67 % were in the 
> 13S fractions. The 13S complexes were estimated to have a molecular weight 
of 401,000 and the molar ratio of antibody to antigen approached 0.5. Therefore, 
these complexes were thought to be composed primarily of one antibody and 
two antigen molecules. The 10S complexes had a molecular weight of 270,000 
and  therefore were  composed of one antibody and one antigen molecule. A 
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FIe.  6.  Disappearance  of  7Cr-anti-TOZ25I  (a'gG)  and  "gG-anti-h, GZ2~I red.  and  alk. 
complexes from the circulation of rabbits  M33  and  M34.  The solid  circles  (e)  and  open 
circles (O)  indicate the experimentally observed points for the disappearance  of  3'G-anti- 
'yG125I and "gG-anti-TG125I  red. and alk. complexes respectively; the solid lines, indicate the 
curves fitted to these points by computer. The larger broken lines  (--)  indicate the three 
exponential components that compose the curve for the 7G-anti-TGl~SI complexes,  and  the 
smaller broken lines (---) indicate the two exponential components that compose the curve for 
the 7G-anti-~/G125I red. and alk. complexes. 
preparation of the  > 13S  fraction of complexes, obtained from the 7G-anti- 
3,G125I complexes made with the first batch of antibodies, required 0.18 #g of 
antibodies to fix 50 % of guinea pig complement. The 13S and 10S complexes 
required  15  /~g  of  antibodies  to  fix  the  same  amount of  complement.  The 
complexes prepared from reduced and alkylated antibodies at fivefold antigen 
excess were given intravenously to rabbits; the complexes were from the first 
antibody preparation  to M33  and M34  and from the second preparation to 
M36  and M37.  With the intact antibodies the disappearance  curve of 7G- 
anti-TGn~I  complexes was  composed  of  three  exponential  components  (see 
Table II and Fig. 6). The first and fastest component had a hag-life of 0.26 hr M.  MANNIK,  WI  AREND,  A.  HALL,  AND  B.  GILLILAND  727 
in M33 and 0.16 hr in M36; 40.1 and 66.5 % of the radioactivity was eliminated 
from the circulation of these rabbits, respectively, at the fast half-lives. These 
percentages are close to the amounts of > 13S complexes in each of the prepa- 
rations. In addition, density gradient separation on sequential serums of M36 
showed the rapid elimination of > 13S  complexes and persistence of 13S  and 
10S  complexes  and  6.6S  antibodies.  In  contrast,  when  the  complexes with 
reduced and alkylated antibodies were administered to rabbits M34 and M37 
(see  Table II),  the disappearance  curves were composed of two exponential 
components  and  the  fastest  component  was  absent.  Furthermore,  density 
gradient separations on sequential serum specimens showed the persistence of 
> 13S complexes along with the smaller components. 
Disappearance of "yM-Anti-'),M Complexes.--In order to evaluate the dis- 
appearance  of  even larger  soluble immune complexes,  the isolated Walden- 
strSm's macroglobulin of a patient was used as the antigen. All preparations of 
this macroglobulin contained some aggregates with sedimentation coefficients 
of 25S and 29S. The antibodies were prepared in the same manner as already 
described; they will be designated anti-'yMl~I and the antibodies with reduced 
and alkylated interchain disulfide bonds will be designated anti-TMl~5I reduced 
and alkylated. At equivalence 92 % of these antibodies were precipitated. Anti- 
gen-antibody complexes were prepared at fivefold antigen excess and charac- 
terized by density gradient ultracentrifugation. These complexes were com- 
posed, using the 19S Waldenstr~Jm's macroglobulin as a marker for calculation 
of sedimentation coefficients,  of >25S,  25S, and 20S  complexes, representing 
58%, 21%, and 15 %, respectively, of the labeled antibodies. The 25S complexes 
were not always clearly identifiable in the preparations before injection but 
became clearly evident and persisted when administered to rabbits  (cf. Figs. 
7 and 9). Furthermore, before injection a 20S peak of antibodies was present, 
but this component was never seen in rabbit circulation. A small peak of 6.6S 
antibodies was present. If the latter was used as a reference point to calculate 
the sedimentation coefficients,  the 25S peak calculated to be 17S according to 
the  methods  of  Martin  and  Ames  (16).  The  concentration  of  sucrose  was 
checked by refractometry in the fractions of the gradient and the gradients were 
found to be linear, except in the top 5-8 % of gradient volume. It was not clear 
why different values were obtained with the two reference points.  The 25S 
complexes were estimated to have a  molecular weight of 1,360,000  and thus 
were thought to be composed of one antigen and three antibody molecules. 
Pools of the various sizes of complexes were made and tested for their ability 
to fix complement. The > 25S complexes,  ranging in size from 31-40S,  required 
0.175/~g  of antibody to fix 50% of complement. The 25S complexes, which also 
contained some larger complexes (see Fig. 7), required 1.2/zg of antibody to fix 
the same amount of complement; the 20S complexes required 3.3/~g of antibody 
to fix 50 % of complement. The complexes prepared from reduced and alkylated 728  ELIMINATION OF  SOLUBLE  COMPLEXES  FRO~  CIRCULATION 
antibodies  were  ineffective in  complement fixation  in  that  more than 43  #g 
of antibodies was needed to fix 50 % of complement. 
The soluble complexes prepared  at fivefold antigen  excess with  the  intact 
and reduced antibodies were given to separate rabbits intravenously. With the 
intact antibodies the disappearance curve of the complexes was composed of 
three exponential components (see Fig. 8 and Table II). The first and fastest 
component had a  half-life of 0.20 hr and 60 %  of the radioactivity was elimi- 
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FIG. 7.  Density gradient ultracentrifugation pattern of -yM-anti-3,Ml2SI (a3'M) com- 
plexes at fivefold  antigen excess. A gradient of 10-50~o sucrose and SW41Ti rotor were used; 
the top of the gradient is represented by 100~o of gradient volume. Pool I represents com- 
plexes from 31 to 40S, pool II, primarily 25S, and pool III, 20S complexes.  The first point on 
the  left represents the counts in the pellet. The arrow indicates the position of 19S 3'M- 
globulin marker. 
nated with  this  half-life.  This percentage was  close  to  the amount  of  >25S 
antibodies in the "yM-anti-3,M125I  preparations. Furthermore, density gradient 
separation on sequential specimens of rabbit M20 showed the rapid elimination 
of > 25S  complexes and persistence of the 25S  complexes and 6.6S  antibodies 
(see Fig. 9). Of note is that in the earliest serum specimens the proportion of 
pelleted material had increased in comparison to the preinjection separation of 
the complexes. Furthermore,  free iodine appeared in  the 1-4-hr specimens as 
evidence of degradation of the rapidly eliminated material. For plotting of the 
serum disappearance curves, only the protein-bound radioactivity was used. 
The complexes prepared with reduced and alkylated anti-'yM125I  also had a 
disappearance  curve  composed  of  three  exponential  components.  The  first M.  M_ANNIK~ W.  AREND~ A.  HALL~ AND  B.  GILLILAND  729 
component had a half-life of 0.25 hr, and 31% of the radioactivity was elimi- 
nated from circulation with this half-life. The presence of the rapid component 
in the disappearance of these complexes prepared with reduced and alkylated 
antibodies is unique  in that  it was not seen with the reduced  and alkylated 
antibodies to HSA, ),-chains, and ~/G-globulins. Density gradient separation of 
100~1  • Observed  points  for 7M-oTM12SI 
50 i~\~  o Observed points for yM oTMlZSI 
i~  ~""~  red.  and  olk. 
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FIC. 8.  Disappearance of 7M-anti-'yMl~5I  (aTM) and  ~,M-anti-TM125I red.  and  alk 
complexes from circulation of rabbits. The solid circles (@) and the open circles (O) indicate 
the  experimentally observed points  for the  disappearance of 7M-anti-'yM125I and  7M- 
anti-TMz25I red. and alk. complexes  respectively; the solid lines indicate the curves fitted to 
these points by computer. The larger broken lines (--) indicate the three exponential com- 
ponents that compose the curve for the ~/M-anti-,yMl~SI  complexes, and the smaller broken 
lines (--) indicate the three exponential components that compose the curve for the 7M- 
anti-TMl~SI red. and alk. complexes. 
sequential serum specimens from this rabbit also disclosed the rapid elimination 
of  >25S material; the 25S  material persisted along with a  shoulder of > 25S 
complexes.  The  initial  rapid  elimination  of  ~/M-anti-qtM125I  reduced  and 
alkylated complexes was not due to rapid elimination of antigen alone, because 
when the antigen was labeled with 125I and administered to a rabbit,  the 19S 
material had a  catabolic half-life of 76 hr.  Only the aggregated ~,M-globulin 
was  quickly  removed.  Partial  aggregation  of  the  antigen  molecules  before 
preparation of complexes could have contributed to the rapid clearance of some 
complexes with reduced and alkylated antibodies. 730  ELIMINATION  OF  SOLUBLE  COMPLEXES  FROM  CIRCULATION 
Experiments were  conducted  to  determine  the  elimination  of  the  immune 
complexes  prepared  from  the  same  anti-TM~2~I  preparations  but  using  as 
antigen the subunits of the 7M-globulin prepared by reduction and alkylation 
(26). However, the 7M-globulin subunits were quickly eliminated from circu- 
lation and because of this all complexes prepared with this antigen were also 
20.3 
quickly removed. 
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FIG. 9.  Density gradient ultracentd/ugation patterns of sequential sera of the rabbit that 
had received 7M-anti-'yM125I (aTM) complexes. Gradients of 10-50% sucrose and SW41TI 
rotor were used. The >25S complexes  are quickly eliminated and the 25S complexes  persist. 
The first points on the left represent the radioactivity recovered in the pellets. 
Disappearance of  HSA-Anti-HSA  Complexes from  Complement Depleted 
Rabbits.--The  experiments described  thus  far were  consistent with  two pos- 
sibilities:  (a)  complement fixation was necessary for rapid removal  of  circu- 
lating immune complexes of sufficient complexity; (b) rapid removal of immune 
complexes of sufficient complexity did not require complement, but this prop- 
erty was altered by reduction and alkylation of the interchain disulfide bonds 
of  antibodies.  To  distinguish  between  these  two  possibilities,  rabbits  were 
depleted  of  complement  components,  the  HSA-anti-HSAI~SI  complexes  at M. M.ANNIK, W. AREND, A. HALL, AND B.  GILLILAND  731 
fivefold antigen excess were administered, and serum specimens were obtained 
and analyzed for disappearance of complexes, as already described. 
Treatment with CoF was started 24 hr before the complexes were given to 
depress the complement level. The complement level remained below 2 CHs0 
units throughout the experiment,  except at the last bleeding (at 96 hr)  the 
complement level was 2 units. In this rabbit 'the disappearance of the HSA- 
anti-HSAl~6I  complexes was indistinguishable from that observed in normal 
rabbits. Three exponential components were present and the fastest component. 
had a half-life of 0.18 -4- 0.01 hr; 46.7 4- 1.6% of antibodies were removed with 
this half-life (for comparison see Table I). 
The aggregated human "yG-globulin was administered before the complexes 
to reduce the complement level and the injections were continued, as outlined 
in Materials and Methods, to keep the complement depressed. The normal com- 
plement was 27 CHs0 units before the aggregates were given but was undetect- 
able before the complexes were administered. However,  8 hr after the com- 
plexes  were  administered,  the  complement level had  increased  to  14  CHs0 
units and then gradually returned to 27-30 CHs0 units in spite of the continued 
administration of the aggregates. In this rabbit the disappearance curve of the 
HSA-anti-HSAI~sI complexes was identical to that observed in normal rabbits. 
The curve was composed of three exponential components and the fastest com- 
ponent had a half-life of 0.21  ~  0.01 hr; 52.0 4-  1.4% of antibodies were re- 
moved with this  half-life. The  complement level did not  remain  depressed 
sufficiently throughout this  experiment but it was  undetectable through at 
least four half-lives of the first component. Therefore, it seemed safe to con- 
clude  that  complement  depletion  with  the  CoF  or  the  aggregated  human 
~¢G-globulin did not alter the clearance of immune complexes  from the circu- 
lation; in particular the rapid initial phase of the clearance of the > llS HSA- 
anti-HSA complexes was not altered. This conclusion was strongly supported 
by data in another paper  2 showing that the uptake of immune complexes by 
the reticuloendothelial system was not diminished by complement depletion. 
DISCUSSION 
Soluble antigen-antibody complexes were prepared in fivefold antigen excess 
with specific isolated rabbit antibodies to antigens of varying size. The isolated 
antibodies were all "yG-globulins  and therefore werc of constant size. The im- 
mune complex preparations with each of the antigens contained complexes of 
variable sizes because of the increasing number of antigen and antibody mole- 
cules involved. However, by virtue of antigens being of variable sizes, immune 
complexes of different sizes were obtained that contained comparable numbers 
of antigens and antibodies. The size of the soluble complexes was characterized 
on linear sucrose density gradients by taking advantage of the i~5I label on the 
antibodies. The soluble complexes in all systems (anti-HSA, anti-k-chains, anti- 732  ELIMINATION  OF  SOLIIBLE  COMPLEXES  FROM  CIRCULATION 
"rG, and anti--rM) had characteristic peaks of antigen-antibody complexes that 
appeared as the smallest stable complexes of the antibodies and the respective 
antigens, ranging from 9S for the h-anti-k complexes to 25S for the ~/M-anti- 
7M complexes,  with llS for the HSA-anti-HSA and 13S for the "yG-anti-'yG 
complexes.  These complexes which were isolated in three systems (anti-HSA, 
anti-'yG, and anti-3,M)  were found to be ineffective in complement fixation. 
The residual complement fixation was thought to be due to rearrangement of 
antigens and antibodies after the removal of excess antigen, and this was ac- 
tually demonstrated with HSA-anti-HSA for the 1  IS complexes.  The l lS com- 
plexes in the HSA-anti-HSA system consisted of one antigen and two antibody 
molecules (AgAb2). The Ag2Ab complexes  in this system would have a  sedi- 
mentation coefficient of 10.2S.  Small amounts of such complexes could have 
existed, but sucrose density gradient experiments disclosed no peak correspond- 
ing to such complexes. HSA possesses  several different antigenic determinants 
that have been recognized by precipitating antibodies (27).  The AgAb2 com- 
plexes in this system must be thermodynamically more stable than the theo- 
retically simpler and smaller Ag~Ab complexes. Since the HSA is a multivalent 
antigen with several different antigenic deternfinants, it is possible that each 
of the antibodies in  these complexes was directed to different antigenic de- 
terminants. The 13S complexes in the qzG-anti--gG  system were calculated to 
consist of Ag2Ab. The 9S material in the k-anti-X system was estimated to con- 
sist of Ag2Ab complexes also. The 25S complexes in the ~M-anti-~,M system 
were estimated to contain AgAb2 to AgAb~ complexes. 
The observation that the AgAb2 complexes did not fix complement is in agree- 
ment with the results of Hyslop et al. (28) who fractionated soluble complexes 
composed of antibodies and antigens with limited valence. They concluded from 
complement-fixation experiments and electron microscopic studies that soluble 
complexes with two antibodies did not fix complement and that complexes with 
four or more antibodies were able to fix complement. Our observations and the 
results of Hyslop et al. (28) are not in conflict wih the conclusion of Cohen (29). 
He studied complement fixation at equivalence with unaltered antibodies  and 
with  chemically altered  antibodies  that were unable  to fix  complement; he 
reached the conclusion that in the lattice of immune complexes two "yG-globu- 
lin molecules had to be adjacent to each other to initiate complement fixation. 
In the AgAb2 complexes the  Fc regions of the antibodies appeared sterically 
apart  under electron microscopy (28), and this may well account for their fail- 
ure to fix complement. 
In the antigen-antibody systems studied, at fivefold antigen excess, larger 
complexes were also present. These ranged from 14-22S  in the HSA-anti-HSA 
complexes, designated as > llS complexes, and these complexes fixed comple- 
ment well. By virtue of their larger size, the > llS complexes were thought to 
contain more antigen and antibody molecules than the AgAb2 complexes. Cor- M.  MANNIK,  W.  AREND,  A.  HALL,  AND  B.  GILLILAND  733 
respondingly larger  complexes were present in the other systems as well and 
they fixed complement efficiently. 
The  antigen-antibody  complexes  that  contained more than  two antibody 
molecules (i.e. more complex than AgAb2) were quickly removed from the circu- 
lation,  the half-lives  ranging  from 0.16 to 0.40 hr  (see Tables I  and II). The 
proportion  of antibodies removed quickly from the circulation  corresponded 
closely to the percentage of antibodies found in the >9S,  >llS,  > 13S, and 
> 25S complexes respectively in the anti-),,  anti-HSA,  anti-'yG,  and anti-'vM 
systems. The rapid removal of these complexes was confirmed by density gradi- 
ent ultracentrifugation of sequential serum samples. Furthermore, in the HSA- 
anti-HSA  system complexes  were prepared  at higher  antigen  excess with  a 
smaller proportion of antibodies in the > llS complexes and a correspondingly 
smaller proportion of antibodies was removed quickly from circulation.  Weigle 
had similarly observed that with increasing antigen excess a larger proportion of 
injected antibodies persisted in circulation  (9). In contrast,  the antigen-anti- 
body complexes  composed of AgAb~ (e.g. HSA-anti-HSA and ~M-anti-~M) 
or AgzAb (e.g. "yG-anti-'yG)  persisted much longer  in the circulation.  These 
were the llS complexes in the HSA-anti-HSA, 13S complexes in the "yG-anti- 
~G and 25S complexes in the "yM-anti-~,M  systems. Thus,  the physical size 
alone in the limits of these experiments did not seem to dictate rapid removal of 
immune complexes. The rapidly removed complexes in the HSA-anti-HSA sys- 
tem ranged from 14S to 22S, yet in the -yM-anti-~,M  system 25S complexes per- 
sisted.  The rapidly removed complexes fixed complement well in all  systems 
examined in these experiments. 
In  the X-anti-X,  HSA-anti-HSA,  and  "yG-anti-~/G  systems,  the first and 
rapid removal of complexes was eliminated when the interchain disulfide bonds 
of antibodies were reduced and alkylated. This alteration of antibodies rendered 
them ineffective in complement fixation when bound with antigens.  As already 
mentioned, the AgAb~ and Ag2Ab complexes  that persisted in the circulation 
were ineffective in complement fixation.  Together these observations suggested 
initially that complement fixation was important in rapid clearance  of immune 
complexes from the circulation  (30). However, if this were true, then depletion 
of complement should alter the clearance  of immune complexes from the circu- 
lation. Depletion of complement components with cobra venom factor or with 
aggregated human  ~G-globulin during  the phase  of rapid clearance of com- 
plexes did not alter the elimination  of HSA-anti-HSA complexes. This observa- 
tion was further  substantiated by measuring  the quantitative uptake of im- 
mune complexes by the reticuloendothelial system in normal and complement- 
depleted rabbits during  the rapid phase of clearance of immune  complexesP 
Therefore, the conclusion was reached that complement fixation is not essential 
for the clearance  from circulation of immune complexes that are composed of 
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altered by cleavage of interchain disulfide bonds, which also diminishes com- 
plement fixation. This alteration of antibody molecules therefore appeared to 
change two separate functions of the ~/G-globulin molecules. The most impor- 
tant parameter for rapid clearance of immune complexes seemed to be their com- 
plexity, in that they had to contain more than two antibody molecules. 
In experiments where bovine serum albumin  or HSA was  administered to 
rabbits for production of acute or chronic glomerulonephritis (10, 3), circulating 
immune complexes were observed that corresponded in size to the llS com- 
plexes observed in our HSA-anti-HSA system. However, in some rabbits >  19S 
complexes were seen in these experiments also, but the characteristics of anti- 
bodies in these complexes were not defined. The results presented in this study 
show that the > llS complexes of HSA-anti-HSA (3,G-globulin antibodies) are 
quickly cleared from the circulation and therefore only serum specimens ob- 
tained shortly after administration of antigen to immunized animals can be ex- 
pected to contain detectable immune complexes of this degree of complexity. 
Soluble AgAb2 complexes can also be achieved with antigens of limited valence. 
The persistence of such complexes in circulation has been demonstrated (31). 
Clearance of soluble immune complexes from the circulation of decomplemented 
animals has not been examined previously. However, Spiegelberg et al.  (32) 
reported  that  mice  decomplemented  with  aggregated  human  ~/G-globulin 
showed normal clearance of carbon particles and decreased clearance of erythro- 
cytes and bacteria coated with specific antibodies. These investigators did not 
define the class of antibodies utilized in their studies. 
The second and third components in the exponential disappearance of im- 
mune complexes, prepared with intact antibodies, were thought to represent 
equilibration and catabolism of the complexes and 6.6S antibodies that survived 
the phase of rapid removal. During the second phase no preferential removal 
of complexes was observed and they persisted during the last exponential phase. 
The second phase showed considerable variation in the half-life, ranging from 
1.45 to 6.48 hr.. The reasons for this were not apparent. The third phase lasted a 
considerable period of time. The mechanism for removal of these complexes is not 
known. Furthermore, the mechanism of catabolism of ~,G-globulin has not been 
elucidated (33). The third phase of removal of immune complexes was closer to 
removal of antigen alone than to removal of antibodies (TG-globulin) alone. This 
was best demonstrated in the HSA-anti-HSA system where the mean half-life for 
the third component was 47 hr (range 40-65 hr), the half-life for lISA was 57 hr, 
and for anti-liSA alone 76 hr. The half-life of -rG-globulin has been shown to vary 
with the serum concentration of this protein; with increased serum levels the half- 
life shortens and with decreased levels the half-life increases (33). The 3,-globulin 
level of several rabbits with varying third phase of clearance of immune com- 
plexes was measured by cellulose acetate  electrophoresis,  but  no  significant 
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or Ag~Ab complexes could not have been caused by differences in the ~,G-glob- 
ulin concentration. 
With reduction and alkylation ofl interchain disulfide bonds of antibodies, 
the disappearance  of immune complexes from the circulation  in the X-anti-X, 
HSA-anti-HSA, and ~/G--anti-~G systems became a two component exponen- 
tial process. The half-life of the first component ranged from 1.0 to 2.2 hr and 
was thought to represent  intra- and extravascular equilibration  since there was 
no preferential loss of heavier  complexes as determined by density gradient 
ultracentrifugation. The second exponential  component was thought to repre- 
sent the catabolic phase, which was slightly longer in the HSA-anti-HSA and 
k-anti-k systems than the comparable  third component for the intact anti- 
bodies. Some rearrangement of immune complexes upon injection into animals 
may well have taken place by virtue of dilution by the intravascular volume. 
This was suggested by density gradients that showed some shift of antibodies 
from the larger complexes to the AgAb~ complexes and 6.6S peak when solutions 
of complexes were compared to the initial serum specimens of rabbits which re- 
ceived these complexes. 
In the "yM-anti-~/M system with reduced and alkylated antibodies, the rapid 
phase of removal of > 25S complexes persisted.  The reasons for this were not 
clear. Preparations of human 7M-globulin frequently contain or develop aggre- 
gates  (34). The preparations of the ~M-globulin used in these experiments 
contained 25S  and 29S material. When this preparation was injected into a 
rabbit, the percentage of counts that corresponded to the percentage  of aggre- 
gates was quickly removed; the remaining material had the expected phases of 
equilibration  and catabolism.  The presence  of aggregated  ~'M-globulin could 
have resulted in rapid clearance of some immune complexes prepared with re- 
duced and alkylated antibodies. 
Even though all the purified antibodies had been isolated by virtue of their 
specificity to antigens coupled to the solid-phase immunoadsorbents,  all immune 
complex preparations in antigen excess contained free antibodies as determined 
by sucrose density gradient ultracentrifugation. This could either be due to de- 
naturation of antibody molecules or to dissociation  of low affinity antibodies 
during the zone centrifugation. If denaturation had occurred and the binding 
site alone was altered,  the antibodies  should have been catabolized  as  ~G- 
globulins and a fourth exponential component should have become apparent in 
computer analysis of the data; this, however, was not observed. 
Several observations from these studies have relevance to the study of human 
immune complex diseases. However,  caution should be exercised in drawing 
parallels between primate and rabbit experiments  in regard to circulating  im- 
mune complexes because immune adherence of antigen-antibody-complement 
complexes to erythrocytes does not occur in rabbits but takes place in man and 
other primates (35). If our studies are applicable to man, then the soluble ira- 736  ELIMINATION  OF  SOLUBLE  COMPLEXES  FROM  CIRCULATION 
mune complexes composed of more than two 3,G-globulin molecules as  anti- 
bodies are rapidly cleared from circulation, and  this in  turn suggests several 
points. First, the rapid clearance of some immune complexes could account for 
the difficulty that has been encountered in the demonstration of immune com- 
plexes in  the  sera  of patients with  systemic lupus erythematosus  and  other 
diseases. Secondly, at least some if the variability in the manifestations of sys- 
temic lupus erythematosus may"  depend on the complexity of antigen-antibody 
complexes produced at any one time.  Thirdly, the low levels of complement 
seen in these patients should not alter the removal of circulating complexes. If 
complement were  important  in  the  elimination  of  circulating immune  com- 
plexes, then markedly low complement levels would cause accumulation of such 
materials and more injury to several organs. 
SUMMARY 
Solid  phase  immunoadsorbents  were  prepared  by  coupling  antigens  to 
agarose.  With  this  technique specific antibodies were easily isolated in large 
amounts. The "yG-globulin class of antibodies isolated in this manner were not 
denatured as judged by their normal biological half-life in rabbits. Soluble im- 
mune complexes at fivefold antigen excess were prepared from isolated specific 
antibodies  and  HSA,  human  k-chains,  human  XG-globulins,  and  a  Walden- 
str6m's macroglobulin as antigens. In all these preparations a characteristic im- 
mune complex was encountered that represented the smallest stable antigen- 
antibody union. In the HSA-anti-HSA system they were found to be AgAb2 
complexes, and Ag2Ab complexes in the "yG-anti-'yG system. These stable com- 
plexes fixed complement ineffectively. Also, a spectrum of larger complexes was 
present in each system, and these complexes fixed complement effectively. 
With intact antibodies the disappearance curves of immune complexes from 
the circulation were composed of three exponential components. The immune 
complexes larger than AgAb2 were quickly removed from the circulation with 
half-lives of 0.09-0.37 hr. Their clearance was not dependent on complement 
components, in that depletion of complement by cobra venom factor and aggre- 
gated ~,G-globulin did not alter the pattern of their removal from the circula- 
tion. However, when the interchain disulfide bonds of antibodies were reduced 
and alkylated, the removal of the X-anti-X, HSA-anti-HSA, and ~/G-anti-~/G 
complexes was altered. In these experiments the disappearance curves were com- 
posed of two exponential components and the rapid removal of the greater than 
AgAb2 complexes did not occur. The immune complexes prepared from reduced 
and alkylated antibodies fixed complement ineffectively. 
The presented data indicate that the rapid removal of circulating immune 
complexes, containing ~G-globulin molecules as antibodies, depends primarily 
on the number of antibodies involved. Furthermore, complement fixation is not 
involved in the rapid removal of such complexes. Nevertheless, the rapid re- M. MANNIK, W. AREND, A. HALL~ AND B. GILLILAND  737 
moval of immune complexes and their ability to fix complement have similari- 
ties for optimal function in that both processes require intact interchain disul- 
fide bonds of antibodies and complexes that exceed the AgAb~ combination. 
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